Literature DB >> 24157559

Guidelines for management of patients with transient ischemic attack.

Toshiyuki Uehara1, Kazuo Minematsu.   

Abstract

A transient ischemic attack (TIA) is a medical emergency that is associated with a high risk of early ischemic stroke and other vascular events. Several evidence-based guidelines have been published to provide recommendations for the evaluation and treatment of patients with TIA. These guidelines underline the need for the urgent referral of patients with TIA so that they can access expert evaluation and immediate treatment. The distinction between TIA and ischemic stroke has recently become less important because these two conditions share pathophysiological mechanisms and many of the preventive approaches are applicable to both. Therefore, current guidelines are often described without a distinction between TIA and ischemic stroke. However, the applicability of recommendations for applying treatment for ischemic stroke to TIA has not been proven. Further studies are required to determine the effects of urgent intervention or treatment early after TIA.
Copyright © 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 24157559     DOI: 10.1159/000351911

Source DB:  PubMed          Journal:  Front Neurol Neurosci        ISSN: 0300-5186


  3 in total

Review 1.  Do Patients With Retinal Artery Occlusion Need Urgent Neurologic Evaluation?

Authors:  Sohan Singh Hayreh
Journal:  Am J Ophthalmol       Date:  2018-08-14       Impact factor: 5.258

2.  Reduction of neuroinflammation alleviated mouse post bone fracture and stroke memory dysfunction.

Authors:  Kang Huo; Meng Wei; Meng Zhang; Zhanqiang Wang; Peipei Pan; Sonali S Shaligram; Jinhao Huang; Leandro B Do Prado; Julia Wong; Hua Su
Journal:  J Cereb Blood Flow Metab       Date:  2021-02-27       Impact factor: 6.200

3.  Small Vessel Transient Ischemic Attack and Lacunar Infarction Detected with Perfusion-Weighted MRI.

Authors:  Hyun-Wook Nah
Journal:  J Stroke       Date:  2017-09-29       Impact factor: 6.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.